Literature DB >> 32463077

The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics Amidst a Pandemic.

Amber C Streifel1, Monica K Sikka2.   

Abstract

Medicare does not reimburse for home infusion; patients requiring outpatient parenteral antimicrobial therapy must seek treatment in high-risk settings. We recommend policy change to allow for adequate social distancing during the coronavirus disease 2019 pandemic.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CMS; COVID-19; Health Insurance Policy; OPAT

Year:  2020        PMID: 32463077      PMCID: PMC7314214          DOI: 10.1093/cid/ciaa658

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  1 in total

1.  Comparison of Adverse Events Among Home- vs Facility-Administered Biologic Infusions, 2007-2017.

Authors:  Matthew C Baker; Yingjie Weng; Robert Fairchild; Neera Ahuja; Nidhi Rohatgi
Journal:  JAMA Netw Open       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.